Srs Capital Advisors, Inc. Spring Works Therapeutics, Inc. Transaction History
Srs Capital Advisors, Inc.
- $1.5 Billion
- Q4 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 67 shares of SWTX stock, worth $2,540. This represents 0.0% of its overall portfolio holdings.
Number of Shares
67
Previous 75
10.67%
Holding current value
$2,540
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SWTX
# of Institutions
241Shares Held
67.4MCall Options Held
260KPut Options Held
316K-
Vanguard Group Inc Valley Forge, PA7.16MShares$271 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$213 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.46MShares$131 Million5.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.27MShares$124 Million0.01% of portfolio
-
State Street Corp Boston, MA3MShares$114 Million0.0% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.37B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...